Literature DB >> 12499679

Vascular endothelial growth factor (VEGF) promotes the early development of bovine embryo in the presence of cumulus cells.

Hailing Luo1, Koji Kimura, Mari Aoki, Makoto Hirako.   

Abstract

Three experiments were conducted to determine the effect of Vascular Endothelial Growth Factor (VEGF) on bovine embryonic development in vitro. Human recombinant VEGF(165) was employed at 5 ng/ml in modified synthetic oviduct fluid. In Exp. 1, bovine cumulus oocyte complexes were matured with or without VEGF for 22 hr, inseminated without VEGF for 6 hr, then cultured with or without VEGF for 42 hr. The cleavage rate and the development rate to 4- to 8-cell were higher (P<0.05) in groups with VEGF during in vitro maturation (IVM, 71.4% and 59.6%), in vitro culture (IVC, 70.3% and 62.3%), and both IVM and IVC (75.9% and 67.8%) than in the group cultured thoroughly without VEGF (49.9% and 38.4%, respectively). In Exp. 2, 4- to 8-cell embryos produced in vitro without VEGF were removed from cumulus cells at 48 hr post-insemination (Pi) and cultured with or without VEGF for 144 hr. The development rates to blastocyst at 96 hr (D6), 120 hr (D7) and 144 hr (D8) were similar (P>0.05) in both groups. In Exp. 3, cumulus cells were removed from presumptive embryos produced by IVM and IVF without VEGF at 10 hr Pi. Denuded embryos were cultured with or without VEGF for 38 hr or 182 hr. The cleavage rate and the development rates to 4- to 8-cell at 48 hr Pi and to blastocyst on D6, D7 and D8 were similar (P>0.05) in all groups. These results suggest that VEGF has a beneficial effect on the initial development of bovine embryo through surrounding cumulus cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499679     DOI: 10.1292/jvms.64.967

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

Review 1.  Bioactive supplements influencing bovine in vitro embryo development.

Authors:  Lydia K Wooldridge; Jessica A Keane; Michelle L Rhoads; Alan D Ealy
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

2.  cDNA microarray analysis of bovine embryo gene expression profiles during the pre-implantation period.

Authors:  Koichi Ushizawa; Chandana B Herath; Kanako Kaneyama; Satoshi Shiojima; Akira Hirasawa; Toru Takahashi; Kei Imai; Kazuhiko Ochiai; Tomoyuki Tokunaga; Yukio Tsunoda; Gozoh Tsujimoto; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2004-11-24       Impact factor: 5.211

3.  An in vitro study on oocyte and follicles of transplanted ovaries treated with vascular endothelial growth factor.

Authors:  Maryam Zand-Vakili; Afsaneh Golkar-Narenji; Paul E Mozdziak; Hussein Eimani
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-12-15

4.  Trade-offs between male fertility reduction and selected growth factors or the klotho response in a lipopolysaccharide-dependent mouse model.

Authors:  Przemyslaw Solek; Jennifer Mytych; Ewelina Sujkowska; Magdalena Grzegorczyk; Patrycja Jasiewicz; Magdalena Sowa-Kucma; Katarzyna Stachowicz; Marek Koziorowski; Anna Tabecka-Lonczynska
Journal:  Toxicol Res       Date:  2021-05-20

5.  Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium.

Authors:  Keiichiro Kizaki; Koichi Ushizawa; Toru Takahashi; Osamu Yamada; Junichi Todoroki; Takashi Sato; Akira Ito; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2008-12-31       Impact factor: 5.211

6.  Profiling of proteins secreted in the bovine oviduct reveals diverse functions of this luminal microenvironment.

Authors:  Viju Vijayan Pillai; Darren M Weber; Brett S Phinney; Vimal Selvaraj
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

7.  Vascular Endothelial Growth Factor A and VEGFR-1 Change during Preimplantation in Heifers.

Authors:  Daniel Chiumia; Anna-Katharina Hankele; Anna E Groebner; Katy Schulke; Horst-Dieter Reichenbach; Katrin Giller; Valeri Zakhartchenko; Stefan Bauersachs; Susanne E Ulbrich
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.